Ultragenyx Pharmaceutical (RARE) Expected to Announce Earnings on Thursday
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of ($1.58) per share and revenue of $145.98 million for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last issued its earnings […]
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of ($1.58) per share and revenue of $145.98 million for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last issued its earnings […]
